Table 4 Consistency between primary and secondary melanoma lesions, according to the BRAF/NRAS mutation status
From: Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Tissue types | Consistency secondary/primary melanomas (%) | Synchronous metastases | Asynchronous metastases |
|---|---|---|---|
Lymph node | 109/120 | 25/26 | 84/94 |
metastasis | (90.8%) | (96.2%) | (89.4%) |
Visceral metastasis | 37/40 | 3/3 | 34/37 |
(92.5%) | (100%) | (91.9%) | |
Brain | 19/24 | 1/1 | 18/23 |
metastasis | (79.2%) | (100%) | (78.3%) |
Skin | 37/52 | 11/14 | 26/38 |
metastasis | (71.2%) | (78.6%) | (68.4%) |
TOTAL | 202/236 | 40/44 | 162/192 |
(85.6%) | (90.9%) | (84.4%) |